Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
作者信息
Eiring A M, Page B D G, Kraft I L, Mason C C, Vellore N A, Resetca D, Zabriskie M S, Zhang T Y, Khorashad J S, Engar A J, Reynolds K R, Anderson D J, Senina A, Pomicter A D, Arpin C C, Ahmad S, Heaton W L, Tantravahi S K, Todic A, Colaguori R, Moriggl R, Wilson D J, Baron R, O'Hare T, Gunning P T, Deininger M W
出版信息
Leukemia. 2017 May;31(5):1253-1254. doi: 10.1038/leu.2017.14.
PMID:28465516
Abstract
摘要
Zotero 插件